UA86951C2 - Применение дезоксипеганина для лечения шизофренических психозов - Google Patents

Применение дезоксипеганина для лечения шизофренических психозов

Info

Publication number
UA86951C2
UA86951C2 UAA200605674A UAA200605674A UA86951C2 UA 86951 C2 UA86951 C2 UA 86951C2 UA A200605674 A UAA200605674 A UA A200605674A UA A200605674 A UAA200605674 A UA A200605674A UA 86951 C2 UA86951 C2 UA 86951C2
Authority
UA
Ukraine
Prior art keywords
desoxypeganine
treatment
schizophrenic psychoses
schizophrenic
psychoses
Prior art date
Application number
UAA200605674A
Other languages
English (en)
Ukrainian (uk)
Inventor
Йоахим Моорманн
Клаус Опитц
Хильке Винтерхофф
Original Assignee
Хф Арцнаймиттельфоршунг Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34625212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA86951(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Хф Арцнаймиттельфоршунг Гмбх filed Critical Хф Арцнаймиттельфоршунг Гмбх
Publication of UA86951C2 publication Critical patent/UA86951C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Дезоксипеганин в форме свободного основания или в форме кислотно-аддитивной соли, или производной дезоксипеганина при условии, что указанное производное является одновременно ингибитором ацетилхолинстеразы и моноаминоксидазы, можно применять для получения лекарственного средства для лечения шизофренического психоза.
UAA200605674A 2003-11-24 2004-11-08 Применение дезоксипеганина для лечения шизофренических психозов UA86951C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10354893A DE10354893B4 (de) 2003-11-24 2003-11-24 Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen

Publications (1)

Publication Number Publication Date
UA86951C2 true UA86951C2 (ru) 2009-06-10

Family

ID=34625212

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200605674A UA86951C2 (ru) 2003-11-24 2004-11-08 Применение дезоксипеганина для лечения шизофренических психозов

Country Status (24)

Country Link
US (1) US20070072947A1 (ru)
EP (1) EP1725229B1 (ru)
JP (1) JP2007512269A (ru)
KR (1) KR20070085036A (ru)
CN (1) CN1886127A (ru)
AR (1) AR046664A1 (ru)
AT (1) ATE424197T1 (ru)
AU (1) AU2004294689B2 (ru)
BR (1) BRPI0416411A (ru)
CA (1) CA2547171A1 (ru)
DE (2) DE10354893B4 (ru)
DK (1) DK1725229T3 (ru)
EA (1) EA012033B1 (ru)
ES (1) ES2323645T3 (ru)
HK (1) HK1093696A1 (ru)
IL (1) IL175772A0 (ru)
MY (1) MY141730A (ru)
NO (1) NO20062666L (ru)
NZ (1) NZ547103A (ru)
SI (1) SI1725229T1 (ru)
TW (1) TW200607507A (ru)
UA (1) UA86951C2 (ru)
WO (1) WO2005053673A1 (ru)
ZA (1) ZA200603543B (ru)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression

Also Published As

Publication number Publication date
AU2004294689A1 (en) 2005-06-16
IL175772A0 (en) 2008-04-13
EP1725229A1 (de) 2006-11-29
DE10354893A1 (de) 2005-06-30
TW200607507A (en) 2006-03-01
DK1725229T3 (da) 2009-06-22
DE502004009105D1 (de) 2009-04-16
AU2004294689B2 (en) 2010-01-07
KR20070085036A (ko) 2007-08-27
EA012033B1 (ru) 2009-06-30
JP2007512269A (ja) 2007-05-17
SI1725229T1 (sl) 2009-08-31
NO20062666L (no) 2006-06-09
ZA200603543B (en) 2007-03-28
HK1093696A1 (en) 2007-03-09
BRPI0416411A (pt) 2007-01-09
AR046664A1 (es) 2005-12-14
WO2005053673A1 (de) 2005-06-16
EP1725229B1 (de) 2009-03-04
NZ547103A (en) 2009-07-31
EA200601016A1 (ru) 2006-10-27
US20070072947A1 (en) 2007-03-29
MY141730A (en) 2010-06-15
CN1886127A (zh) 2006-12-27
ES2323645T3 (es) 2009-07-22
ATE424197T1 (de) 2009-03-15
DE10354893B4 (de) 2011-03-10
CA2547171A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
TW200505881A (en) Tri(cyclo) substituted amide compounds
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MY161991A (en) Proteasome inhibitors
EP1583534A4 (en) 3-AMINO-4-PHENYLBUTANIC ACID DERIVATIVES AS DIPEPTIDYL-PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
MY141780A (en) 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
MY166653A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
TW200714589A (en) Phenylacetamides suitable as protein kinase inhibitors
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
UA88481C2 (ru) Донепезила фумарат, пригодный для получения фармацевтических композиций
PL1758852T3 (pl) Podstawione związki cyklopentenu
EP1736157A4 (en) MEDIUM AGAINST JUCKREIZ
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
TW200519111A (en) N3-substituted imidazopyridine C-KIT inhibitors
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
MXPA05010020A (es) Derivados de oxamida.
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MY141020A (en) Novel pparalpha and ppargamma agonists
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
CY1109762T1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
IL183104A0 (en) Method for production of candesartan
UA86951C2 (ru) Применение дезоксипеганина для лечения шизофренических психозов